Ottonova
German digital-first private health insurer (PKV) for freelancers and expats.
On the record
Checkpoint: FY2025 SFCR/annual report filing showing audited loss and insured-book size
The call
Nine years and $175M in, Ottonova still has a small book and no fresh funding, leaving Debeka or a peer insurer as its most likely next chapter.
Ottonova sells private health insurance in Germany through a smartphone app and website, cutting out the paperwork and agents that traditional insurers use. The company has a government license and must hold money in reserve for claims, which stops new startups and AI from competing directly, but big insurance companies like Debeka (which already invested in Ottonova) can copy the digital experience and use their size and cash to do it faster and cheaper. The one thing that could prove Ottonova can win on its own is if it shows in its next yearly report that it's growing customers quickly and finally making money, but if it keeps shrinking or stays flat, the most likely outcome is that Debeka or another big insurer simply buys it.
Why
01
AI pressure: None apparent. AI can automate claims and chat support but cannot hold the BaFin license or actuarial reserves that let a firm sell private health insurance in Germany. Could AI do the core job? Only partly.
02
Bigger players: Debeka (also an Ottonova investor), plus Allianz, AXA, DKV, Signal Iduna. Debeka funded Ottonova's Series D then can simply digitize its own massive PKV book, making Ottonova's tech edge a feature, not a defense. Could a giant copy it? Yes, easily.
03
What protects it. BaFin license and actuarial reserves keep casual entrants out, but that same wall protects Debeka and other big insurers too.
What would change this call
Ottonova's FY2025 SFCR filing (expected mid-2026) shows insured-book size and net loss. Reveals whether the book is scaling past critical mass or stalling.
Any new priced funding round announced within 6 to 12 months. Shows if investors still back Ottonova's independent growth path.
An acquisition or strategic recap announcement involving Debeka or another PKV incumbent. Would confirm consolidation into an incumbent rather than standalone scale.
Any new priced funding round announced within 6 to 12 months. Shows if investors still back Ottonova's independent growth path.
An acquisition or strategic recap announcement involving Debeka or another PKV incumbent. Would confirm consolidation into an incumbent rather than standalone scale.
Key numbers
- ~5,470 insured clients as of last count
- €2.3M net loss in 2024
- ~$174-180M raised since 2015, none since Sept 2022
Named risks
- No priced funding round since September 2022, raising sustainability concerns.
- Sub-scale customer base (about 5,470 clients) after 9 years versus incumbents with millions.
- Reported EUR 2.3M net loss in 2024 with unverified audited financials.
- Investor Debeka is simultaneously a direct competitor, creating conflicting incentives.
- AI-driven aggregators and chat tools commoditizing its concierge and claims-triage differentiation.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Debeka | gaining on | Also an Ottonova investor (Series D, Nov 2019) and major PKV incumbent with far greater scale, as of 2025-09 |
| Feather | contesting | Berlin digital insurer actively targeting Ottonova's expat niche with comparison content, as of 2025-07-04 |
| Signal Iduna | losing to | Cited with about 2.4 million customers versus Ottonova's roughly 5,470, as of 2025-07-04 |
| Allianz, AXA, DKV | losing to | Large incumbents hold same BaFin license and greater capital to digitize faster, per 2026 analysis |
Questions people ask
- Is Ottonova profitable in 2026?
- No confirmed profitability. A third-party review cites a 2.3 million euro net loss for Ottonova in 2024 with only about 5,470 private health insurance clients as of 2023, per allaboutberlin.com, published 2026-06-03. Audited FY2025 SFCR figures are expected mid-2026.
- Has Ottonova raised new funding recently?
- No priced round has been disclosed since its Series F in September 2022 (about $33.8M, led by Cadence Growth Capital). CB Insights still lists that round as 'Alive' as of April 2026, indicating no newer disclosed capital raise.
- Who owns Ottonova and is Debeka involved?
- Ottonova is privately, venture-backed, with Debeka Krankenversicherungsverein VVaG both an investor (led its Series D, November 2019, about $66.1M) and a major competing incumbent, an unusual dual role confirmed via Northdata filings dated 2025-09.
- Could AI replace Ottonova's insurance business?
- No. Ottonova holds a BaFin insurance license (granted 20 June 2017) and carries actuarial reserve obligations under German law that AI cannot assume. AI can commoditize its chat/claims-triage features, but not its regulated underwriting core.
- Who is Ottonova's biggest competitor?
- Feather, a Berlin-based digital insurer targeting the same expat segment, is its closest digital-native rival as of 2025-07-04. Larger incumbents like Debeka, Signal Iduna (about 2.4 million customers), Allianz, AXA and DKV dwarf Ottonova's roughly 5,470 clients.
- How many customers does Ottonova have?
- A 2026-06-03 third-party review (allaboutberlin.com) states Ottonova had about 5,470 private health insurance clients in 2023, a small figure compared to incumbents like Signal Iduna's cited 2.4 million customers as of 2025-07-04.
Timeline
- 2026-04-25CEO Bernhard Brühl says Ottonova is 'not going away' amid scale skepticism
- 2025-09Northdata filing shows Debeka and ATHOS listed as shareholders
- 2024Ottonova reports about 2.3 million euro net loss (third-party estimate)
- 2023-01-01Dr. Bernhard Brühl becomes CEO; founder Rittweger moves to Supervisory Board Chair
- 2022-09Series F raise, about $33.8M led by Cadence Growth Capital, last disclosed round
- 2021-08Series E raise, about $47.3M led by Earlybird Venture Capital
- 2019-11Series D raise, about $66.1M led by Debeka
- 2017-06-20Ottonova receives BaFin operating license
- 2017-03Series B raise, about $16.2M
- 2015-12-01Ottonova founded by Roman Rittweger, Sebastian Scheerer, Frank Birzle
Revision history
23 July 2026
First assessed. Protection under test. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- About us
- ottonova, Apps on Google Play (2026-02-15)
- ottonova - Headcount, Funding & Open Jobs (2026-05-14)
- Products, Competitors, Financials, Employees, Headquarters Locations (2026-04-25)
- Changes at The Top At Ottonova (2023-01-03)
- ottonova Revenue, Funding & Valuation (2022-10-01)
- Revenue, Competitors, Alternatives (2022-04-18)
- Should you trust Ottonova? An objective review (2026-06-03)
- Ottonova 2026 Company Profile
- Ottonova Review, What is Good & Bad about it [2026] (2026-05-23)
- Best private health insurance in Germany: Our top 3 (2025-07-04)